Cocaine addiction remains without an effective pharmacotherapy and is characterized by an inability of addicts to inhibit relapse to drug use. Vulnerability to relapse arises from an enduring impairment in cognitive control of motivated behavior, manifested in part by dysregulated synaptic potentiation and extracellular glutamate homeostasis in the projection from the prefrontal cortex to the nucleus accumbens. Here we show in rats trained to self-administer cocaine that the enduring cocaine-induced changes in synaptic potentiation and glutamate homeostasis are mechanistically linked through group II metabotropic glutamate receptor signaling. The enduring cocaine-induced changes in measures of cortico-accumbens synaptic and glial transmission were restored to predrug parameters for at least 2 wk after discontinuing chronic treatment with the cystine prodrug, N-acetylcysteine. N-acetylcysteine produced these changes by inducing an enduring restoration of nonsynaptic glutamatergic tone onto metabotropic glutamate receptors. The long-lasting pharmacological restoration of cocaine-induced glutamatergic adaptations by chronic N-acetylcysteine also caused enduring inhibition of cocaine-seeking in an animal model of relapse. These data mechanistically link nonsynaptic glutamate to cocaineinduced adaptations in excitatory transmission and demonstrate a mechanism to chronically restore prefrontal to accumbens transmission and thereby inhibit relapse in an animal model. C ocaine addiction remains without an effective pharmacotherapy and is characterized by an inability of addicts to inhibit relapse to drug use. An enduring cocaine-induced impairment in cognitive control of motivated behavior contributes to the vulnerability to relapse (1, 2). Projections from the frontal cortex to the basal ganglia constitute a primary brain substrate for regulating motivated behavior (3). Cocaine-induced neuropathologies in the projection from the prefrontal cortex to the nucleus accumbens are implicated in cocaine addiction (4), including impaired neuroplasticity and synaptic communication (4, 5) . For example, prefrontal synapses in the accumbens undergo enduring potentiation (6-9), and the ability of these synapses to increase or decrease synaptic strength is impaired (7, 10). In addition, withdrawal from chronic cocaine use increases both presynaptic release estimated by elevated frequency of miniature excitatory postsynaptic currents (mEPSC) and by postsynaptic strength measured as increases in the surface expression of AMPA glutamate receptors and the ratio of AMPA/NMDA currents at glutamatergic synapses (6, 8, 11) .
Cocaine addiction remains without an effective pharmacotherapy and is characterized by an inability of addicts to inhibit relapse to drug use. Vulnerability to relapse arises from an enduring impairment in cognitive control of motivated behavior, manifested in part by dysregulated synaptic potentiation and extracellular glutamate homeostasis in the projection from the prefrontal cortex to the nucleus accumbens. Here we show in rats trained to self-administer cocaine that the enduring cocaine-induced changes in synaptic potentiation and glutamate homeostasis are mechanistically linked through group II metabotropic glutamate receptor signaling. The enduring cocaine-induced changes in measures of cortico-accumbens synaptic and glial transmission were restored to predrug parameters for at least 2 wk after discontinuing chronic treatment with the cystine prodrug, N-acetylcysteine. N-acetylcysteine produced these changes by inducing an enduring restoration of nonsynaptic glutamatergic tone onto metabotropic glutamate receptors. The long-lasting pharmacological restoration of cocaine-induced glutamatergic adaptations by chronic N-acetylcysteine also caused enduring inhibition of cocaine-seeking in an animal model of relapse. These data mechanistically link nonsynaptic glutamate to cocaineinduced adaptations in excitatory transmission and demonstrate a mechanism to chronically restore prefrontal to accumbens transmission and thereby inhibit relapse in an animal model. C ocaine addiction remains without an effective pharmacotherapy and is characterized by an inability of addicts to inhibit relapse to drug use. An enduring cocaine-induced impairment in cognitive control of motivated behavior contributes to the vulnerability to relapse (1, 2) . Projections from the frontal cortex to the basal ganglia constitute a primary brain substrate for regulating motivated behavior (3) . Cocaine-induced neuropathologies in the projection from the prefrontal cortex to the nucleus accumbens are implicated in cocaine addiction (4) , including impaired neuroplasticity and synaptic communication (4, 5) . For example, prefrontal synapses in the accumbens undergo enduring potentiation (6) (7) (8) (9) , and the ability of these synapses to increase or decrease synaptic strength is impaired (7, 10) . In addition, withdrawal from chronic cocaine use increases both presynaptic release estimated by elevated frequency of miniature excitatory postsynaptic currents (mEPSC) and by postsynaptic strength measured as increases in the surface expression of AMPA glutamate receptors and the ratio of AMPA/NMDA currents at glutamatergic synapses (6, 8, 11) .
Neuroimaging in cocaine addicts reveals reduced activity in prefrontal cortex under baseline conditions, but marked hyperresponsiveness in the prefrontal cortex and accumbens that is correlated with a desire for drug upon exposure to drug-associated stimuli (12) . Similarly, animal models of relapse show that activation of this pathway is necessary and sufficient to reinstate cocaine-seeking behavior (13) and that neuronal activity in pyramidal neurons in prefrontal cortex projecting to medium spiny neurons (MSNs) in the nucleus accumbens core (NAcore) region is correlated with cocaine-seeking (14, 15) . Accordingly, it is thought that prefrontal-to-accumbens synapses undergo enduring potentiation after chronic cocaine use that contributes to relapse vulnerability (4, 6, 16).
Possibly linked to a cocaine synaptic pathology is a long-lasting impairment in nonsynaptic glutamate release and transport, a process termed 'glutamate homeostasis' (4). Cystine-glutamate exchange regulates extrasynaptic glutamate levels by providing a 1:1 stoichiometric exchange of extracellular cystine for intracellular glutamate (17) (18) (19) , and along with glutamate transport, it is down-regulated following repeated cocaine administration (20, 21) . In this way, chronic cocaine use reduces basal levels of extracellular glutamate, thereby decreasing tone upon perisynaptic metabotropic glutamate receptors (mGluR) known to regulate glutamatergic synaptic transmission (22) (23) (24) . Supporting involvement of this adaptation in relapse, administering cystine prodrugs to acutely activate the exchanger inhibits reinstated cocaine-seeking in animal models (20, 25, 26) .
Despite the value of acutely administered pharmacotherapies, a drug regimen that induces long-lasting repair of cocaine-induced neuropathologies and enduring protection from relapse would have greater therapeutic utility. Thus, we sought to determine (i) whether chronic treatment with a cystine prodrug causes enduring repair of cocaine-induced neuropathologies in prefrontal-toaccumbens glutamatergic synapses, (ii) how the repair of the extrasynaptic and synaptic neuropathologies are mechanistically linked, and (iii) whether synaptic restoration translates into reduced cocaine-seeking in an animal model of relapse.
Results
Enduring Relapse Protection by Chronic N-Acetylcysteine. We adapted the extinction-reinstatement model of relapse to cocaineseeking (27) . Rats were trained to lever press for i.v. cocaine for 12 d, followed by 12 d of extinction training, during which lever pressing no longer delivered cocaine (Fig. 1A) . Two hours before each extinction session, animals received the cystine prodrug Nacetylcysteine (100 mg/kg, i.p.) or vehicle. The rats then underwent 2-3 additional weeks of cocaine withdrawal in the absence of extinction training or N-acetylcysteine treatments to evaluate longlasting effects of N-acetylcysteine on glutamate homeostasis, synaptic physiology, and conditioned cue-or cocaine-induced reinstatement of lever pressing (cocaine-seeking behavior). Control animals received an i.v. saline infusion that was yoked to cocaine infusions in rats self-administering cocaine. This protocol of cocaine self-administration, N-acetylcysteine treatment, and withdrawal was used throughout the study.
In the first experiment, reinstatement trials were conducted to estimate the effect of N-acetylcysteine on reinstated cocaineseeking 2 h after N-acetylcysteine or vehicle on days 25 and 29 and again on days 43 and 47 after leaving the rats in their home cages for 2-3 wk without drug treatments (Fig. 1A) . Animals trained to self-administer cocaine were divided into two groups such that levels of active lever pressing across the last 3 d of cocaine self-administration were equivalent in each group (Fig.  1b) . The N-acetylcysteine-treated animals showed an initial reduction in lever pressing during extinction training, although by 2 wk the levels of extinction pressing were equivalent between the vehicle and N-acetylcysteine groups (Fig. 1B) . Reduced extinction lever pressing unlikely resulted from nonspecific motor inhibition since acute N-acetylcysteine does not inhibit locomotor activity or operant responding (25) .
Cocaine-seeking was elicited by presenting cues (tone and light) previously paired with cocaine delivery during self-administration or by injecting cocaine (10 mg/kg, i.p) just before the cue-reinstatement session. Reinstated lever pressing induced by either modality was inhibited in the N-acetylcysteine pretreated group (days 25 and 29; Fig. 1C ) compared with the vehicletreated group. More importantly, 2-3 wk after discontinuing N-acetylcysteine or vehicle treatments, both cue-induced and cocaine-and cue-induced reinstatement remained inhibited in the N-acetylcysteine group (Fig. 1D ).
Enduring Restoration of Glutamate Homeostasis in the NAcore. The reduction in basal extracellular concentrations of glutamate in the NAcore by chronic cocaine use is a marker of disrupted glutamate homeostasis, arising from an enduring reduction in cystine-glutamate exchange (20, 21, 25) . Basal extracellular glutamate concentrations assayed in the NAcore by in vivo microdialysis arise largely from cystine-glutamate exchange rather than from synaptic activity (19) . In the next experiment, we measured basal glutamate levels after the daily treatment regimen of N-acetylcysteine to determine whether the reduction in cocaine-seeking was associated with restoration of nonsynaptic glutamate in the extracellular space ( Fig. 2A) . Animals trained to self-administer cocaine and treated with saline vehicle during extinction training showed reduced basal levels of glutamate compared with yoked-saline controls using no-net-flux microdialysis (Fig. 2B) . However, basal extracellular glutamate levels in cocaine-trained animals were restored to control levels when measured 2-3 wk after the last daily injection of N-acetylcysteine. In contrast, the N-acetylcysteine regimen did not alter glutamate in yoked-saline rats. Fig. 2C shows the location of the active zone of the microdialysis probes in the NAcore.
Enduring Restoration of Synaptic Strength and Role of mGluR2/3. The long-lasting normalization of extracellular glutamate by Nacetylcysteine (Fig. 2B ) may increase glutamatergic tone onto perisynaptic mGluR2/3 (28) that negatively regulate synaptic glutamate release (23, (29) (30) (31) . To examine this possibility, stimulating electrodes were placed into the prefrontal cortex and Reinstatement of active lever pressing by cues (tone and light) or cocaine and cues (10 mg/kg, i.p.) was significantly inhibited both in the presence of NAC (days 25 and 29) (C) and 2-3 wk after discontinuing NAC treatment (days 43 and 47) (D). Student's t tests revealed Cue25: t(37) = 2.67, P = 0.011; Cocaine29: t(37) = 4.12, P < 0.001; Cue43: t(37) = 3.13, P = 0.003; Cocaine47: t(37) = 3.14, P = 0.003. *P < 0.05 comparing NAC to saline-treated groups. There was no difference in the slope of the regression line between the four groups. *P < 0.05 for (cocaine, saline) compared with the other three groups using a Bonferroni test for multiple comparisons. (C) Summary and micrograph example of the location of the active membrane of the dialysis probe in the NAcore according to Paxinos and Watson (47) . ac, anterior commissure; arrows, dorsal and ventral extent of the active dialysis membrane.
recording electrodes into the NAcore to elicit field potentials as an estimate of the overall strength of prefrontal to NAcore synapses ( Fig. 3B; ref. 7 ). This protocol permits selective activation of prefrontal afferents to the NAcore in an in vivo environment where glutamate homeostasis is not disrupted (32) . We previously found a long-term potentiation (LTP)-like shift to the left of the input-output curve 3 wk after the last cocaine self-administration session (7) . Similarly, 4-5 wk after the last cocaine exposure, the input-output curve for rats trained to selfadminister cocaine was potentiated compared with yoked-saline controls (Fig. 3A) . This LTP-like shift was abolished 2-3 wk after completing daily N-acetylcysteine. In contrast, N-acetylcysteine did not alter the input-output curve in yoked-saline animals.
The importance of mGluR2/3 in N-acetylcysteine-induced restoration of synaptic strength was examined by infusing the mGluR2/3 antagonist LY341495 through a microdialysis probe attached to the recording electrode (Fig. 3B) . To validate this methodology, reverse-dialysis of the AMPA receptor antagonist, CNQX, or the mGluR2/3 agonist, LY379268, to drug-naive animals reduced field potential amplitude (Fig. S1) . Infusing receptor-selective concentrations (33) of LY341495 into the NAcore potentiated evoked field potentials in yoked-saline rats (Fig. 3C) . The increase in field amplitude was absent in cocainetrained rats treated with vehicle during extinction training, indicating decreased tone on mGluR2/3 commensurate with reduced basal extracellular concentrations of glutamate (Fig. 1B) . However, similar to controls, LY341495 potentiated prefrontalto-NAcore synaptic transmission in rats receiving N-acetylcysteine during extinction training. Therefore, the capacity of LY341495 to block inhibitory mGluR2/3 tone and potentiate field potentials was restored by N-acetylcysteine administration during extinction training, corroborating the enduring restoration of extracellular glutamate levels (Fig. 2B ).
Enduring Relapse Protection by Restoring Glutamatergic Tone to mGluR2/3. Up to this point the data show an enduring normalization of glutamate homeostasis by N-acetylcysteine, and thereby a mGluR2/3-dependent depotentiation of prefrontal-to-NAcore excitatory synapses. Given the postulated role by heightened accumbens glutamatergic transmission in cocaine relapse (4), we asked whether the long-lasting protection from reinstated cocaine-seeking provided by the chronic N-acetylcysteine treatment regimen was also mGluR2/3-dependent. In this experiment, animals treated with N-acetylcysteine during extinction were microinjected with the mGluR2/3 antagonist LY341495 into the NAcore (Fig. 4A) . Blockade of mGluR2/3 prevented N-acetylcysteine-induced inhibition of reinstated cocaine-seeking in the presence of N-acetylcysteine (days 25 and 29) and 2-3 wk after the last N-acetylcysteine injection (days 43 and 47) (Fig. 4B) . In contrast, LY341495 did not alter reinstated responding in control animals (Fig. 4C ). These data demonstrate that N-acetylcysteine induced a long-lasting restoration of glutamatergic tone onto mGluR2/3, thereby normalizing synaptic strength and causing an enduring reduction in reinstated cocaine-seeking.
Enduring Restoration of Both Presynaptic and Postsynaptic Glutamate Transmission. The experiments so far demonstrate that Nacetylcysteine produced an enduring increase in nonsynaptic glutamate (Fig. 2B ) that impinges on mGluR2/3 (Fig. 3D) to normalize synaptic strength (Fig. 3A) . Since the measure of Fig. 3 . N-acetylcysteine (NAC) restores synaptic strength in prefrontal cortex projections to the NAcore through modulating mGluR2/3 receptors. (A) Inputoutput curve measured in the NAcore following in vivo stimulation of the prefrontal cortex. The increase in field amplitude in rats with a history of cocaine self-administration was reduced by NAC treatment during extinction training; two-way ANOVA [treatment group F(3, 150) = 3.83; P = 0.022; stimulation intensity F(6, 18) = 409.3; P < 0.001; interaction F(18, 150) = 1.77; P = 0.034]. *P < 0.05, for comparing cocaine, saline to other groups using a Bonferroni post hoc test. (B) Illustration of the experimental preparation where a dialysis probe and adjacent recording electrode were implanted into the NAcore. (C) Field potentials (normalized to levels following aCSF) were increased in yoked-saline control and NAC, but not vehicle-treated animals trained to self-administer cocaine after two concentrations of the mGluR2/3 antagonist LY341495 were delivered through a dialysis probe. Two-way repeated-measures ANOVA revealed significant group and time effects of LY341495 [group: F (2, 493) = 5.07, P = 0.019; time: F(29, 493) = 1.59, P = 0.027]. (Inset) Mean ± SEM normalized field amplitude averaged over the last 10 min (last 5 data samples were averaged) after 20 μm LY341495 [one-way ANOVA: F(2, 19) = 7.04, P = 0.006]. *P < 0.05 for (cocaine, saline) compared with other groups using a Bonferroni multiple comparisons test.
synaptic strength was via field potentials in vivo, it is unclear if Nacetylcysteine's effects were primarily presynaptic, postsynaptic, or both. To further examine the role of glutamate homeostasis in presynaptic regulation of excitatory transmission in the NAcore, we measured mEPSC in MSNs using whole-cell patch recordings in tissue slices obtained from rats treated as in Fig. 2A . Presynaptic release probability was estimated by measuring the frequency of mEPSC after eliminating action potential-evoked glutamate release with tetrodotoxin (TTX) (29, 34, 35) . The frequency of mEPSC was elevated in NAcore MSNs recorded in cocaine-trained subjects compared with yoked-saline controls, and this increase was abolished when measured 2-3 wk after the last N-acetylcysteine injection (Fig. 5 A and B) . In contrast to mEPSC frequency, there was no effect by either cocaine or Nacetylcysteine on mEPSC amplitude (Fig. 5C) . Also, spontaneous EPSC (sEPSC) recorded in the absence of TTX showed an increased frequency in cocaine rats treated with vehicle, but not in cocaine rats that received N-acetylcysteine treatment, and no treatment group differed in sEPSC amplitude (Fig. S2) . These results indicate that by restoring extracellular glutamate (Fig.  2B ) and glutamatergic tone on presynaptic release-regulating mGluR2/3s (Fig. 3 C and D) , chronic N-acetylcysteine normalizes presynaptic glutamate release probability.
To estimate the postsynaptic effects of cocaine and Nacetylcysteine on glutamatergic synaptic transmission, we recorded the ratio of peak AMPA to NMDA receptor-mediated currents. Recordings were restricted to the dorsomedial NAcore, and stimulation electrodes were placed dorsomedial to the recording electrode to preferentially stimulate prefrontal afferents (36) . Akin to a previous report with chronic cocaine followed by withdrawal (8), cocaine-trained rats showed an increase in AMPA: NMDA relative to yoked-saline controls (Fig. 5D ). The AMPA: NMDA ratio elevation was reversed in animals treated with Nacetylcysteine during extinction training, supporting an enduring normalization of postsynaptic strength by N-acetylcysteine. Considering the observed changes in AMPA:NMDA ratio, the lack of effect on mEPSC or sEPSC amplitude was surprising. This discrepancy between mEPSC amplitude and AMPA:NMDA ratio is not uncommon and is thought to result from mEPSC arriving from diverse excitatory synapses onto a neuron, whereas the evoked EPSC is largely thought to result from prefrontal afferents (35, 37) .
Discussion
This study outlines a treatment strategy with daily N-acetylcysteine that inhibits cocaine-seeking initiated by either cocaine-conditioned cues or a noncontingent injection of cocaine in animals withdrawn from self-administered cocaine. Importantly, Nacetylcysteine inhibition of cocaine-seeking endured for at least 2 wk after the last daily N-acetylcysteine injection (Fig. 1) . The inhibition of cocaine-seeking by N-acetylcysteine was then linked to its ability to restore neuroadaptations produced by cocaine selfadministration on glutamate homeostasis and synaptic glutamate transmission (see Fig. S3 for qualitative model). Chronic Nacetylcysteine increases cystine-glutamate exchange and the expression of the glial glutamate transporter GLT-1 (21, 26) . The net result is an increase in extracellular, nonsynaptic glutamate (Fig. 2B ) that restored tone onto presynaptic release-regulating mGluR2/3 (Fig. 3C) , thereby normalizing synaptic strength in prefrontal to NAcore afferents (Fig. 3A) . The normalization of synaptic strength in the NAcore arose from restoring both presynaptic release probability (Fig. 5B) and postsynaptic potentiation as estimated by the AMPA:NMDA current ratio (Fig. 5D) . The importance of these mechanisms in cocaine relapse was shown by blocking the N-acetylcysteine-induced inhibition of reinstated cocaine-seeking with a microinjection of a mGluR2/3 antagonist into the NAcore (Fig. 4B) . Importantly, akin to inhibiting reinstated cocaine-seeking, the N-acetylcysteine-induced amelioration of the cocaine-induced glutamatergic neuroadaptations endured for at least 2 wk after discontinuing daily Nacetylcysteine. The long-lasting normalization of both cellular and behavioral impairments in an animal model of relapse supports the potential clinical utility of a strategy to restore glutamate homeostasis in treating cocaine addiction.
The profile of physiological responses normalized by Nacetylcysteine is remarkable by ranging from extracellular, nonsynaptic glutamate concentration to measures of both presynaptic and postsynaptic glutamate transmission. Although this regulation supports the concept that homeostasis between synaptic and nonsynaptic glutamate release is important in cocaineinduced pathophysiology (4), some underlying mechanisms linking glutamate homeostasis to synaptic plasticity remain unclear. For example, although the data in Fig. 4 show that normalizing function at mGluR2/3 is critical in the relapse protection afforded by chronic N-acetylcysteine, it is unclear how stimulation of presynaptic mGluR2/3 function and corresponding reduction in synaptic glutamate release probability also restores postsynaptic measures, such as the AMPA:NMDA ratio.
Multiple synaptic mechanisms can be considered. First, elevating extrasynaptic glutamate concentrations also stimulates group I mGluRs (mGluR1/5) (7). The stimulation of mGluR1/5 induces long-term depression that has been associated with an endocannabinoid-mediated reduction in presynaptic glutamate 
release (38) and a rise in intracellular Ca
2+ that internalizes AMPA receptors and/or substitutes high-conductance AMPA receptor subunits with the low-conductance GluR2 AMPA receptor subunit (39) . Such a mechanism within the NAcore may explain the reduction of AMPA:NMDA ratio after N-acetylcysteine treatment. However, behavioral studies indicate that activation of mGluR5 likely promotes the reinstatement of drugseeking in animal models (7, 40) , indicating that either this mechanism does not contribute to decreasing postsynaptic strength or that decreasing postsynaptic strength is not critical to the suppression of cocaine-seeking by N-acetylcysteine.
Second, although regulating cystine-glutamate exchange in the NAcore modulates reinstated cocaine-seeking (20) , it is important to consider that systemically administered N-acetylcysteine will have broader actions that could indirectly influence glutamate homeostasis and synaptic plasticity in the NAcore. For example, basal activity in the prefrontal cortex is blunted in human addicts and in animal models (12, 15) , and by restoring activity to the prefrontal cortex, N-acetylcysteine could decrease action potential-mediated synaptic glutamate release and elicit homeostatic down-regulation of AMPA receptors (41) .
Finally, the possibility exists that the reduction in AMPA: NMDA ratio does not represent a decrease in excitatory transmission due to reducing AMPA receptors, but rather a potentiation due to an increase in NMDA currents. It has been shown that mGluR1/5 stimulation potentiates striatal NMDA receptormediated currents (42, 43) , and by indirectly stimulating mGluR1/ 5, N-acetylcysteine may enhance NMDA currents and reduce the AMPA:NMDA ratio. However, this explanation seems unlikely because cocaine does not alter NMDA currents in the accumbens (8), and we found that the evoked NMDA current amplitude and decay time-constants did not differ across treatment groups (Fig.  S4) , suggesting that there is no change in kinetics or subunit composition of NMDA receptors after N-acetylcysteine treatment (44) .
Together, this series of experiments indicates that pharmacological restoration of glutamate homeostasis with daily Nacetylcysteine may provide a mechanism for treating cocaine dependence, a possibility also indicated by a recent pilot clinical trial with N-acetylcysteine in nicotine dependence (21) . Moreover, because restoring tone to release-regulating presynaptic mGluR2/ 3 was identified as a critical link between restoring glutamate homeostasis and synaptic potentiation, stimulating mGluR2/3 with direct or allosteric agonists may be therapeutically beneficial. Indeed, mGluR2/3 agonist administration systemically or into the NAcore inhibits cue-or cocaine-reinstated drug seeking (45, 46) . Thus, N-acetylcysteine alone or in combination with drugs targeting other key proteins contributing to glutamate homeostasis, including metabotropic glutamate receptors and glutamate transporters, may prove effective treatments for inhibiting relapse in addiction to cocaine and perhaps other drugs of abuse.
Methods
Animal Housing and Surgery. All experiments were conducted in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals, and the Institutional Animal Care and Use Committee at the Medical University of South Carolina approved all procedures. Male Sprague-Dawley rats were single housed, and food intake was maintained at ∼25 g/d. Rats were anesthetized with ketamine/xylazine and implanted with i.v. catheters. For in vivo intracranial experiments, rats were stereotaxically implanted with bilateral guide cannulae aimed at the NAcore according to Paxinos and Watson (47) .
Self-Administration, Extinction, and Reinstatement Procedures. Daily selfadministration consisted of 12 d at >10 infusions/2-h session (lever press = 0.2 mg in 0.05 mL cocaine infusion over 2 s and a 5-s presentation of light-and tone-conditioned cues). Paired yoked saline controls were used. Extinction sessions began on the day after the final self-administration session and continued for 2 wk, after which rats were left in their home cages for 2-3 wk. Following the extinction period, animals underwent cue and cocaineand cue-primed (10 mg/kg) reinstatement trials (Fig. 4A) . For the microinjection reinstatement study, a counterbalanced cross-over design was used, and LY341495 (2 μg/0.5 μL per side) or artificial cerebrospinal fluid (aCSF) were infused over 2 min. In Vivo Microdialysis and Glutamate Quantification. Probes were constructed as described (48) . The night before the experiment, a probe was inserted through an indwelling guide cannula, and the following morning 20-min samples were collected. Glutamate was measured using HPLC with electrochemical detection (48) .
In Vivo Field Potentials. Rats were anesthetized with urethane and mounted in a stereotaxic apparatus. Concentric bipolar stimulating electrodes were placed in the ventral prelimbic prefrontal cortex, glass recording electrodes were aimed at the dorsomedial region of the accumbens, and field potential amplitude was recorded (7) . In some field recordings, microdialysis probes were attached to recording electrodes (0.5-to 1.0-mm separation) and lowered into the NAcore to deliver an mGluR2/3 agonist or antagonist (2 μL/min flow rate).
Slice Preparation and In Vitro Whole Cell Recording. Rats were administered ketamine/xylazine and transcardially perfused with aCSF. Coronal brain slices were collected and incubated in recording aCSF at 35°. Recordings targeted the dorsomedial NAcore where in vivo recordings were made and prefrontal inputs are most dense (36, 49) . MSNs were visualized using video microscopy. Picrotoxin was used to block inhibitory synaptic transmission. EPSC were recorded under −80 mV voltage clamp whole-cell configuration using glass microelectrodes and were evoked using bipolar stimulation at ∼100-200 μm dorsomedial of the recorded cell. AMPA currents were isolated by applying the NMDA receptor antagonist D-AP5 at +40 mV, and NMDA currents were obtained by subtracting the AMPA current from the total current (8) . mEPSC were recorded in presence of bath applied TTX, with detection criteria set at >7 pA (37) . Cumulative probability plots were generated using 400-600 consecutive events.
Histology and Statistics. For the microinjection and microdialysis studies, fixed brains were sectioned (100 μm thick) and stained with a Nissl stain. For field potential studies, pontamine sky blue was used to mark the recording site at the end of each recording session (7) . Parametric statistical analysis were used for behavioral and electrophysiology data as indicated, and for greater than two groups, a Bonferroni multiple comparison post hoc comparison was used. For the no-net-flux analysis, linear regression with a Bonferroni correction for multiple comparisons was used. F values are reported in the figure legends when significant (P < 0.05).
